ALA.AX · AROVELLA THERAPEUTICS LIMITED
Australia · RS rating 20 · As of 2026-10-14
| Price | 0.05 AUD |
|---|---|
| 1-day change | -7.0% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 31 / 23 / 30 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 16 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +47.0% |
| Market cap (USD) | $43.7M |